Search Results - "Negoescu, Diana M."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: A Cost-Effectiveness Analysis in a Simulated Cohort by Negoescu, Diana M, Enns, Eva A, Swanhorst, Brooke, Baumgartner, Bonnie, Campbell, James P, Osterman, Mark T, Papamichael, Konstantinos, Cheifetz, Adam S, Vaughn, Byron P

    Published in Inflammatory bowel diseases (01-01-2020)
    “…Proactive therapeutic drug monitoring of infliximab is a marginally cost-effective strategy for Crohn’s disease, whereas reactive therapeutic drug monitoring…”
    Get full text
    Journal Article
  2. 2

    Does mothers' and caregivers' access to information on their child's vaccination card impact the timing of their child's measles vaccination in Uganda? by Griffith, Bridget C, Cusick, Sarah E, Searle, Kelly M, Negoescu, Diana M, Basta, Nicole E, Banura, Cecily

    Published in BMC public health (26-04-2022)
    “…On-time measles vaccination is essential for preventing measles infection among children as early in life as possible, especially in areas where measles…”
    Get full text
    Journal Article
  3. 3

    Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis by Winetsky, Daniel E, Negoescu, Diana M, DeMarchis, Emilia H, Almukhamedova, Olga, Dooronbekova, Aizhan, Pulatov, Dilshod, Vezhnina, Natalia, Owens, Douglas K, Goldhaber-Fiebert, Jeremy D

    Published in PLoS medicine (01-11-2012)
    “…Prisons of the former Soviet Union (FSU) have high rates of multidrug-resistant tuberculosis (MDR-TB) and are thought to drive general population tuberculosis…”
    Get full text
    Journal Article
  4. 4

    Dynamic Learning of Patient Response Types: An Application to Treating Chronic Diseases by Negoescu, Diana M., Bimpikis, Kostas, Brandeau, Margaret L., Iancu, Dan A.

    Published in Management science (01-08-2018)
    “…Currently available medication for treating many chronic diseases is often effective only for a subgroup of patients, and biomarkers accurately assessing…”
    Get full text
    Journal Article
  5. 5

    Differentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic Analysis by Negoescu, Diana M., Zhang, Zhenhuan, Bucher, Heiner C., Bendavid, Eran

    Published in Clinical infectious diseases (15-06-2017)
    “…Background. Viral load (VL) monitoring for patients receiving antiretroviral therapy (ART) is recommended worldwide. However, the costs of frequent monitoring…”
    Get full text
    Journal Article
  6. 6

    Balancing Immunological Benefits and Cardiovascular Risks of Antiretroviral Therapy: When Is Immediate Treatment Optimal? by Negoescu, Diana M., Owens, Douglas K., Brandeau, Margaret L., Bendavid, Eran

    Published in Clinical infectious diseases (15-11-2012)
    “…We developed a mathematical model to identify the timing of antiretroviral therapy (ART) initiation that optimizes patient outcomes as a function of patient…”
    Get full text
    Journal Article
  7. 7

    Sales Channel Optimization via Simulations Based on Observational Data with Delayed Rewards: A Case Study at LinkedIn by Negoescu, Diana M, Khosravi, Pasha, Zhao, Shadow, Chen, Nanyu, Ahammad, Parvez, Gonzalez, Humberto

    Published 16-09-2022
    “…Training models on data obtained from randomized experiments is ideal for making good decisions. However, randomized experiments are often time-consuming,…”
    Get full text
    Journal Article
  8. 8

    Epsilon: Privacy Metric for Machine Learning Models by Negoescu, Diana M, Gonzalez, Humberto, Orjany, Saad Eddin Al, Yang, Jilei, Lut, Yuliia, Tandra, Rahul, Zhang, Xiaowen, Zheng, Xinyi, Douglas, Zach, Nolkha, Vidita, Ahammad, Parvez, Samorodnitsky, Gennady

    Published 20-07-2023
    “…We introduce Epsilon*, a new privacy metric for measuring the privacy risk of a single model instance prior to, during, or after deployment of privacy…”
    Get full text
    Journal Article